EVALUATION OF CURRENT SCENARIO OF CANCER DISEASE AT CHATTAGRAM IN BANGLADESH
Keywords:
Cancer, Chittagong Medical College Hospital, treatment ways, used drugsAbstract
Objective: Now a day Cancer is the furthermost dangerous diseases. It can develop almost anywhere in the body. Cancer is a disease whose treatment process takes too long time and also too costly.
Methods: This is a survey work on cancer due to current increasing of the number of cancer patients in Bangladesh. This evaluation was conceded in Chittagong Medical College Hospital, Bangladesh, from 10th November 2019 to 25th February 2020. Here, 31 cancer patients were evaluated.
Results: In this work, it is observed that most of the cancer patients were female. In this study, it was also observed the cancer was occurred highly at the age of 41-50 years (30%), then age limit 31-40 (20%).Most of the female are bearing ovary cancer (26%) and Breast cancer (29%) and also male are affected by Thyroid cancer (26%). We found that 60% of patients were being treated with chemotherapy alone. Doctors were commonly prescribed of chemo drugs Cisplatin (21%) and Folinic acid (29%).
Conclusion: Government should highlight on the expansion of specific cancer center. Such types of centers can also deliver rehabilitation as well as relaxing care for dangerous cancer patients to release their highdistress.
Peer Review History:
Received 6 December 2019; Revised 11 January 2020; Accepted 27 February; Available online 15 March 2020
Academic Editor: Dr. Amany Mohamed Alboghdadly, Princess Nourah bint abdulrahman university, Riyadh, amalbgadley@pnu.edu.sa
Received file: Reviewer's Comments:
Average Peer review marks at initial stage: 4.0/10
Average Peer review marks at publication stage: 7.0/10
Reviewer(s) detail:
Dr. Dalia Kamal Zaffar Ali, Modern University for technology and information, Egypt, dr.moda88@gmail.com
Dr. Mohammad Tauseef, Department of Pharmaceutical Sciences, College of Pharmacy, Chicago State University, mtauseef@csu.edu
Downloads
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.